BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31484281)

  • 21. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
    Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
    Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathologic features and prognostic analysis of 104 patients with gastric neuroendocrine neoplasms].
    Liang W; Gao Y; Li J; Cui J; Xi H; Cai A; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):427-31. PubMed ID: 27112478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathological features and outcome of gastroenteropancreatic high-grade (WHO G3) neuroendocrine tumors: a study of 60 cases].
    Huang D; Tan C; Weng WW; Ni SJ; Wang L; Sheng WQ
    Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):12-16. PubMed ID: 31914528
    [No Abstract]   [Full Text] [Related]  

  • 24. The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.
    Okubo Y; Motohashi O; Nakayama N; Nishimura K; Kasajima R; Miyagi Y; Shiozawa M; Yoshioka E; Suzuki M; Washimi K; Kawachi K; Nito M; Kameda Y; Yokose T
    Diagn Pathol; 2016 Nov; 11(1):128. PubMed ID: 27821179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
    Lv Y; Han X; Xu XF; Ji Y; Zhou YH; Sun HC; Zhou J; Fan J; Lou WH; Huang C
    BMC Cancer; 2019 Apr; 19(1):335. PubMed ID: 30961559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
    Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
    Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes of gastroduodenal neuroendocrine tumors according to their WHO grade: A single-institutional retrospective analysis.
    Ryu DG; Kim SJ; Choi CW; Kang DH; Kim HW; Park SB; Nam HS; Lee SH; Hwang SH
    Medicine (Baltimore); 2022 Sep; 101(37):e30397. PubMed ID: 36123854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors.
    Del Prete M; Di Sarno A; Modica R; Lassandro F; Giorgio A; Bianco A; Muto M; Gasperi M; Del Prete F; Colao A; Montesarchio V; Faggiano A;
    J Endocrinol Invest; 2017 Dec; 40(12):1373-1380. PubMed ID: 28667452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of diagnosis, therapy and prognosis factors of 103 patients with pancreatic neuroendocrine tumors].
    Luo Q; Liu YN; Ma HY; Li S; Huang JY; Li G; Jin G
    Zhonghua Wai Ke Za Zhi; 2017 Oct; 55(10):755-759. PubMed ID: 29050176
    [No Abstract]   [Full Text] [Related]  

  • 31. Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.
    Shin Y; Ha SY; Hyeon J; Lee B; Lee J; Jang KT; Kim KM; Park YS; Park CK
    Cancer Res Treat; 2015 Oct; 47(4):738-46. PubMed ID: 25687852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathological features and prognosis of patients with gastric neuroendocrine carcinoma from multiple centers in southern China].
    Fang C; Wang W; Zhang Y; Feng X; Zeng Y; Li Y; Chen J; Chen Y; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1230-1234. PubMed ID: 27928791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.
    Yang Z; Klimstra DS; Hruban RH; Tang LH
    Am J Surg Pathol; 2017 Jul; 41(7):915-922. PubMed ID: 28498280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic analysis and clinicopathological features of 20 patients with appendiceal neuroendocrine neoplasms].
    Mao W; Lyu Y; Pu N; Li J; Xin B; Chen W; Jin D; Lou W; Xu X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):564-568. PubMed ID: 29774940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.
    Guo LJ; Wang CH; Tang CW
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):284-8. PubMed ID: 27170574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors.
    Martin JA; Warner RRP; Aronson A; Wisnivesky JP; Kim MK
    Pancreas; 2017 Oct; 46(9):1214-1218. PubMed ID: 28902794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of tumor grade on pancreatic neuroendocrine tumors.
    Shyr BS; Shyr BU; Chen SC; Shyr YM; Wang SE
    Asian J Surg; 2022 Dec; 45(12):2659-2663. PubMed ID: 35246343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grade 3 Neuroendocrine Tumor (G3 NET) in a Background of Multiple Serotonin Cell Neoplasms of the Ileum Associated with Carcinoid Syndrome and Aggressive Behavior.
    Capuano F; Grami O; Pugliese L; Paulli M; Pietrabissa A; Solcia E; Vanoli A
    Endocr Pathol; 2018 Dec; 29(4):369-373. PubMed ID: 30076568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroenteropancreatic neuroendocrine tumors in Iceland: a population-based study.
    Gudmundsdottir H; Möller PH; Jonasson JG; Björnsson ES
    Scand J Gastroenterol; 2019 Jan; 54(1):69-75. PubMed ID: 30638086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management and Survival Analysis of Gastrointestinal Neuroendocrine Tumors by Different Tumor Characteristics: Tertiary Center Experience.
    Gonulal B; Bilgic Y; Akbulut S; Karabulut E; Samdanci ET
    J Gastrointest Cancer; 2022 Dec; 53(4):915-920. PubMed ID: 34524616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.